Concepedia

Philip Hampel

PH

Statistics

Publications

8

Citations

330

H-Index

8

Active since

2017

Affiliations

University of Veterinary Medicine Hannover, Foundation(Current)

University of Helsinki

University of Copenhagen

Hannover Re (Germany)

Philip Hampel is an author at University of Veterinary Medicine Hannover, Foundation specializing in medicine, neuropharmacology, and pharmacology.

ORCID

Publications per year

2017–2023

8

Publications

8

Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain

Kerstin Römermann, Maren Fedrowitz, Philip Hampel et al. · Neuropharmacology · 2017 · 76 citations

, , +15

Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy

Marina Bershteyn, Sonja Bröer, Mansi Parekh et al. · Cell stem cell · 2023 · 69 citations · Full text

, , +16

Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy

Claudia Brandt, Patricia Seja, Kathrin Töllner et al. · Neuropharmacology · 2018 · 42 citations · Full text

, , +6

Phenobarbital and midazolam suppress neonatal seizures in a noninvasive rat model of birth asphyxia, whereas bumetanide is ineffective

Marie Johne, Kerstin Römermann, Philip Hampel et al. · Epilepsia · 2020 · 41 citations · Full text

, , +17

Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B

Philip Hampel, Kerstin Römermann, Nanna MacAulay et al. · Scientific Reports · 2018 · 40 citations · Full text

, , +8

1–5 of 8